Yusuf Özkay

9PUBLICATIONS
19CO-AUTHORS
Biomolecular modelling and designMolecular targetsCheminformatics and quantitative structure-activity relationshipsBiologically active molecules
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Aug 13, 2026
Design, Synthesis, In Silico ADME, Toxicity Prediction and Molecular Docking Studies of Benzimidazole-Oxadiazole Derivatives for α-Glucosidase and Aldose Reductase Pathways as Potent Anti-Diabetic Agents.

|Jul 03, 2026
Design, Synthesis and Biological Effects Studies of Novel EGFR Inhibitors Targeting Wild-Type and Mutant EGFR (EGFR-L858R and EGFR-L858R/T790M).

|Jan 05, 2026
Design and Synthesis of Thiadiazole Derivatives as Dual EGFR/COX‑2 Inhibitors with Anticancer and Anti-inflammatory Activities.

Arzu Hidir, Derya Osmaniye, Begüm Nurpelin Sağlik Özkan

|Sep 08, 2025
Design, Synthesis, and Molecular Docking Studies of Novel Pyrazoline-Thiazoles as Cholinesterase Dual-Target Inhibitors for the Treatment of Alzheimer's Disease.

Betül Kaya, Ulviye Acar Çevik, Bilge Çiftçi

|Aug 25, 2025
Targeting Cancer with New Morpholine-Benzimidazole-Oxadiazole Derivatives: Synthesis, Biological Evaluation, and Computational Insights.

Gresa Halimi Syla, Derya Osmaniye, Büşra Korkut Çelikateş

|Aug 11, 2025
Design, Synthesis, In Silico Absorption, Distribution, Metabolism, and Elimination and Molecular Docking Studies of Thiazole-Based Furan Derivatives, and Their Biological Evaluation for Alzheimer Disease Therapy.

Abdüllatif Karakaya, Ulviye Acar Çevik, Betül Kaya

Pageof 2

Frequent Collaborators

8 joint publications

Zafer Asım Kaplancıklı

4 joint publications

Derya Osmaniye

4 joint publications

Ulviye Acar Çevik

3 joint publications

Şükrü Beydemir